Cidara Therapeutics Inc (CDTX)’s Stock Price Falls Due To Weak Fundamental Momentum
Cidara Therapeutics Inc (NASDAQ:CDTX) has a beta value of 1.17 and has seen 1.34 million shares traded in the last trading session. The company, currently
Cidara Therapeutics Inc (NASDAQ:CDTX) has a beta value of 1.17 and has seen 1.34 million shares traded in the last trading session. The company, currently
In the last trading session, 1.17 million shares of the Cidara Therapeutics Inc (NASDAQ:CDTX) were traded, and its beta was 1.17. Most recently the company’s
Cidara Therapeutics Inc (NASDAQ:CDTX)’s traded shares stood at 0.41 million during the last session, with the company’s beta value hitting 1.17. At the close of
In the last trading session, 1.15 million Cidara Therapeutics Inc (NASDAQ:CDTX) shares changed hands as the company’s beta touched 1.10. With the company’s per share
Cidara Therapeutics Inc (NASDAQ:CDTX) has a beta value of 0.80 and has seen 3.7 million shares traded in the recent trading session. The company, currently
© 2024, Powered by Smart TechOne